Please assess the completion status of the following clinical trial:

Trial Title: Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Maxillar bone cyst with diameter larger than 2 cm and smaller than 4 cm~* Understanding and written acceptance of assay conditions~* Informed written consent of the patient for assay and for surgery~* In women, negative pregnancy test at t=0~* In women, compromise of using anticonceptive methods during the study~Exclusion Criteria:~* Age under 18 or over 65~* Incapacity or legal dependence~* Pregnancy, lactancy, or enrollment in fertility programs~* Previous or concomitant oncological processes.~* Positive serology for HIV-1 orHIV-2, Hepatitis B (HBsAg, Anti-HCV-Ab) or Hepatitis C (Anti-HCV-Ab).~* Immunocompromised patients~* Systemic disease with potential effects on bone metabolism~* Congenital or acquired maxillofacial malformation~* Patients with prescription of drugs acting on bone metabolism, suc as glucocorticoids and bisphosphonates~* Active or recent infection of the cyst~* Recidive of the cyst (previous surgery)~* Participation in other trials or studies in the last 3 months.~* Other pathologic conditions or circumstances that difficult participation in the study according to medical criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- MSV treatment (Type: EXPERIMENTAL): MSV treatment: Mesenchymal stem cells from bone marrow expanded by GMP-compliant procedure in IBGM cell production unit in autologous plasma scaffold and implanted in maxillary bone cavities after cyst removal

Based on this trial design, predict the completion outcome and termination type (if applicable).